Renal angiomyolipomatosis and Kaposi's sarcoma: a possible link disrupted by sirolimus.
Giovanni
G
Stallone
Barbara
B
Infante
Luciano
L
Tartaglia
Francesca
F
Bruno
Loreto
L
Gesualdo
Giuseppe
G
Grandaliano
D000368:Aged; D018207:Angiomyolipoma / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D000971:Antineoplastic Combined Chemotherapy Protocols; D001706:Biopsy; D003131:Combined Modality Therapy; D003520:Cyclophosphamide; D004317:Doxorubicin; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000175:diagnosis; D009392:Nephrectomy; D011241:Prednisone; D012514:Sarcoma, Kaposi / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy* / Q000532:radiotherapy; D020123:Sirolimus / Q000627:therapeutic use*; D013156:Splenectomy; D014057:Tomography, X-Ray Computed; D014750:Vincristine
D007166:Immunosuppressive Agents; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone; D020123:Sirolimus